Status:
RECRUITING
abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release
Lead Sponsor:
Gelre Hospitals
Collaborating Sponsors:
Deventer Ziekenhuis
Conditions:
Carpal Tunnel Syndrome
Wound Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Carpal Tunnel Syndrome is a prevalent condition, up to 9% in women and 0.6% in men. Surgical decompression in the most effective treatment. After surgery, approximately 1,8% of the patients develop a ...
Detailed Description
Carpal Tunnel Syndrome is a prevalent condition; up to 9% in women and 0.6% in men. It causes complaints of paresthesia, pain, numbness and loss of strength. Surgical decompression is the most effecti...
Eligibility Criteria
Inclusion
- • indication for carpal tunnel release
Exclusion
- carpal tunnel syndrome which has yet been operated
- injection with corticosteroids
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2028
Estimated Enrollment :
2604 Patients enrolled
Trial Details
Trial ID
NCT05431101
Start Date
May 1 2022
End Date
April 1 2028
Last Update
August 26 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gelre Ziekenhuizen
Apeldoorn, Netherlands, 7334DZ
2
Deventer Ziekenhuis
Deventer, Netherlands, 7416SE